首页|外泌体miR-145和miR-21在非小细胞肺癌中的研究进展

外泌体miR-145和miR-21在非小细胞肺癌中的研究进展

扫码查看
非小细胞肺癌(non-small cell lung cancer,NSCLC)是全球发病率最高的恶性肿瘤之一,大多数患者在确诊时已是中晚期,预后极差.外泌体是细胞主动分泌的直径为40~100 nm的膜小体,包含丰富的蛋白质、microRNAs(miRNAs)等物质,参与细胞间的物质交换和信息交流.非小细胞肺癌源性的外泌体miRNA参与调节肿瘤细胞的发生发展、侵袭及转移等过程,在肿瘤细胞的生理、病理过程中扮演了重要角色.本文将系统阐述外泌体的生物学特性、生物学功能以及外泌体miR-145和miR-21在调控非小细胞肺癌进展、早期诊断、治疗靶点筛选及预后中的作用,为外泌体miRNA基础研究与临床应用提供参考.
Research progress of exosome miR-145 and miR-21 in non-small cell lung cancer
Non-small cell lung cancer(NSCLC)is one of the malignant tumors with the highest incidence in the world.Most patients are in the middle and advanced stage when diagnosed,and the prognosis is extremely poor.Exosomes are membrane bodies with a diameter of 40~100 nm that are actively secreted by cells,containing rich substances such as proteins,lipids,microRNAs(miRNAs),and mRNAs,which are involved in the exchange of substances and information between cells.Non-small cell lung cancer(NSCLC)-derived exosome miRNAs are involved in regulating the occurrence,development,invasion and metastasis of non-small cell lung cancer tumor cells,playing an important role in the physiological and pathological processes of tumor cells.This paper will systematically describe the biological characteristics and functions of exosomes,as well as the role of exosomes miR-145 and miR-21 in regulating the progression,early diagnosis,therapeutic target screening and prognosis of non-small cell lung cancer,so as to provide reference for the basic research and clinical application of exosome miRNA.

non-small cell lung cancerexosomesmiR-145miR-21biomarkers

罗翰林、武伦、冉凤英、陈浩

展开 >

湖北医药学院附属国药东风总医院心胸大血管外科,十堰 442000

湖北医药学院附属国药东风总医院实验中心,十堰 442000

非小细胞肺癌 外泌体 miR-145 miR-21 生物标志物

国家自然科学基金湖北省教育厅科学研究计划指导性项目十堰市科技局指导性项目十堰市科技局指导性项目

82272960B202116521Y7322Y85

2023

生命的化学
中国生物化学与分子生物学会

生命的化学

CSTPCD
影响因子:0.404
ISSN:1000-1336
年,卷(期):2023.43(4)
  • 5